nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
|
Gerber, Nicolas U. |
|
2012 |
48 |
13 |
p. 2028-2036 9 p. |
artikel |
2 |
Cancer risk and prevention in a globalised world: Solving the public policy mismatch
|
Sullivan, R. |
|
2012 |
48 |
13 |
p. 2043-2045 3 p. |
artikel |
3 |
Carcinoma of endocrine organs: Results of the RARECARE project
|
van der Zwan, Jan Maarten |
|
2012 |
48 |
13 |
p. 1923-1931 9 p. |
artikel |
4 |
Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative
|
Abu Ajaj, Khalid |
|
2012 |
48 |
13 |
p. 2054-2065 12 p. |
artikel |
5 |
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
|
Huiart, Laetitia |
|
2012 |
48 |
13 |
p. 1939-1946 8 p. |
artikel |
6 |
Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer
|
Mishra, Vivek |
|
2012 |
48 |
13 |
p. 2075-2085 11 p. |
artikel |
7 |
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
|
Brandberg, Y. |
|
2012 |
48 |
13 |
p. 2012-2019 8 p. |
artikel |
8 |
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
|
Coté, Michele L. |
|
2012 |
48 |
13 |
p. 1957-1968 12 p. |
artikel |
9 |
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada
|
Hedden, Lindsay |
|
2012 |
48 |
13 |
p. 1969-1976 8 p. |
artikel |
10 |
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
|
Speeckaert, Reinhart |
|
2012 |
48 |
13 |
p. 2004-2011 8 p. |
artikel |
11 |
Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest
|
Shao, Jingwei |
|
2012 |
48 |
13 |
p. 2086-2096 11 p. |
artikel |
12 |
Local therapy is critical in localised pelvic rhabdomyosarcoma: Experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee
|
Réguerre, Yves |
|
2012 |
48 |
13 |
p. 2020-2027 8 p. |
artikel |
13 |
Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database
|
Garcia-Etienne, Carlos A. |
|
2012 |
48 |
13 |
p. 1947-1956 10 p. |
artikel |
14 |
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
|
Bartsch, Rupert |
|
2012 |
48 |
13 |
p. 1932-1938 7 p. |
artikel |
15 |
SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer
|
Knappskog, Stian |
|
2012 |
48 |
13 |
p. 1988-1996 9 p. |
artikel |
16 |
Socio-economic implications of cancer survivorship: Results from the PROFILES registry
|
Mols, Floortje |
|
2012 |
48 |
13 |
p. 2037-2042 6 p. |
artikel |
17 |
Successful centralisation of patients with vulvar carcinoma: A population-based study in The Netherlands
|
van den Einden, Loes C.G. |
|
2012 |
48 |
13 |
p. 1997-2003 7 p. |
artikel |
18 |
Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes
|
Liedtke, Cornelia |
|
2012 |
48 |
13 |
p. 2066-2074 9 p. |
artikel |
19 |
Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008
|
Hollestein, L.M. |
|
2012 |
48 |
13 |
p. 2046-2053 8 p. |
artikel |
20 |
Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
|
Chen, Liping |
|
2012 |
48 |
13 |
p. 1977-1987 11 p. |
artikel |